Literature DB >> 22250086

Activation of the NLRP3 inflammasome by group B streptococci.

Alessandro Costa1, Rahul Gupta, Giacomo Signorino, Antonio Malara, Francesco Cardile, Carmelo Biondo, Angelina Midiri, Roberta Galbo, Patrick Trieu-Cuot, Salvatore Papasergi, Giuseppe Teti, Philipp Henneke, Giuseppe Mancuso, Douglas T Golenbock, Concetta Beninati.   

Abstract

Group B Streptococcus (GBS) is a frequent agent of life-threatening sepsis and meningitis in neonates and adults with predisposing conditions. We tested the hypothesis that activation of the inflammasome, an inflammatory signaling complex, is involved in host defenses against this pathogen. We show in this study that murine bone marrow-derived conventional dendritic cells responded to GBS by secreting IL-1β and IL-18. IL-1β release required both pro-IL-1β transcription and caspase-1-dependent proteolytic cleavage of intracellular pro-IL-1β. Dendritic cells lacking the TLR adaptor MyD88, but not those lacking TLR2, were unable to produce pro-IL-1β mRNA in response to GBS. Pro-IL-1β cleavage and secretion of the mature IL-1β form depended on the NOD-like receptor family, pyrin domain containing 3 (NLRP3) sensor and the apoptosis-associated speck-like protein containing a caspase activation and recruitment domain adaptor. Moreover, activation of the NLRP3 inflammasome required GBS expression of β-hemolysin, an important virulence factor. We further found that mice lacking NLRP3, apoptosis-associated speck-like protein, or caspase-1 were considerably more susceptible to infection than wild-type mice. Our data link the production of a major virulence factor by GBS with the activation of a highly effective anti-GBS response triggered by the NLRP3 inflammasome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22250086      PMCID: PMC3273589          DOI: 10.4049/jimmunol.1102543

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  Group B streptococcal beta-hemolysin induces mortality and liver injury in experimental sepsis.

Authors:  Axel Ring; Johann S Braun; Jürgen Pohl; Victor Nizet; Wolfgang Stremmel; Jerry L Shenep
Journal:  J Infect Dis       Date:  2002-05-22       Impact factor: 5.226

2.  Group B streptococcal beta-hemolysin/cytolysin promotes invasion of human lung epithelial cells and the release of interleukin-8.

Authors:  Kelly S Doran; Jennifer C W Chang; Vivian M Benoit; Lars Eckmann; Victor Nizet
Journal:  J Infect Dis       Date:  2002-01-03       Impact factor: 5.226

3.  Beta 2 integrins are involved in cytokine responses to whole Gram-positive bacteria.

Authors:  M Cuzzola; G Mancuso; C Beninati; C Biondo; F Genovese; F Tomasello; T H Flo; T Espevik; G Teti
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

4.  Recognition of yeast nucleic acids triggers a host-protective type I interferon response.

Authors:  Carmelo Biondo; Giacomo Signorino; Alessandro Costa; Angelina Midiri; Elisabetta Gerace; Roberta Galbo; Antonella Bellantoni; Antonio Malara; Concetta Beninati; Giuseppe Teti; Giuseppe Mancuso
Journal:  Eur J Immunol       Date:  2011-07       Impact factor: 5.532

5.  Role of interleukin 12 in experimental neonatal sepsis caused by group B streptococci.

Authors:  G Mancuso; V Cusumano; F Genovese; M Gambuzza; C Beninati; G Teti
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

6.  Interleukin-18 is an essential element in host resistance to experimental group B streptococcal disease in neonates.

Authors:  Vitaliano Cusumano; Angelina Midiri; Valentina Valeria Cusumano; Antonella Bellantoni; Giuseppe De Sossi; Giuseppe Teti; Concetta Beninati; Giuseppe Mancuso
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Mitogen-activated protein kinases and NF-kappa B are involved in TNF-alpha responses to group B streptococci.

Authors:  Giuseppe Mancuso; Angelina Midiri; Concetta Beninati; Giovanna Piraino; Andrea Valenti; Giacomo Nicocia; Diana Teti; James Cook; Giuseppe Teti
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

8.  Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection.

Authors:  G Teti; G Mancuso; F Tomasello
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

9.  Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease.

Authors:  Giuseppe Mancuso; Angelina Midiri; Concetta Beninati; Carmelo Biondo; Roberta Galbo; Shizuo Akira; Philipp Henneke; Douglas Golenbock; Giuseppe Teti
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

10.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.

Authors:  Fabio Martinon; Kimberly Burns; Jürg Tschopp
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

View more
  63 in total

Review 1.  Molecular mechanisms regulating NLRP3 inflammasome activation.

Authors:  Eun-Kyeong Jo; Jin Kyung Kim; Dong-Min Shin; Chihiro Sasakawa
Journal:  Cell Mol Immunol       Date:  2015-11-09       Impact factor: 11.530

Review 2.  Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies.

Authors:  Jay Vornhagen; Kristina M Adams Waldorf; Lakshmi Rajagopal
Journal:  Trends Microbiol       Date:  2017-06-17       Impact factor: 17.079

3.  A multicomponent toxin from Bacillus cereus incites inflammation and shapes host outcome via the NLRP3 inflammasome.

Authors:  Anukriti Mathur; Shouya Feng; Jenni A Hayward; Chinh Ngo; Daniel Fox; Ines I Atmosukarto; Jason D Price; Kristina Schauer; Erwin Märtlbauer; Avril A B Robertson; Gaetan Burgio; Edward M Fox; Stephen H Leppla; Nadeem O Kaakoush; Si Ming Man
Journal:  Nat Microbiol       Date:  2018-12-10       Impact factor: 17.745

4.  Diminished Capsule Exacerbates Virulence, Blood-Brain Barrier Penetration, Intracellular Persistence, and Antibiotic Evasion of Hyperhemolytic Group B Streptococci.

Authors:  Claire Gendrin; Sean Merillat; Jay Vornhagen; Michelle Coleman; Blair Armistead; Lisa Ngo; Anjali Aggarwal; Phoenicia Quach; Jacob Berrigan; Lakshmi Rajagopal
Journal:  J Infect Dis       Date:  2018-03-13       Impact factor: 5.226

Review 5.  Immunity to uropathogens: the emerging roles of inflammasomes.

Authors:  Claire Hamilton; Lionel Tan; Thomas Miethke; Paras K Anand
Journal:  Nat Rev Urol       Date:  2017-03-07       Impact factor: 14.432

Review 6.  Role of innate immunity in neonatal infection.

Authors:  Alex G Cuenca; James L Wynn; Lyle L Moldawer; Ofer Levy
Journal:  Am J Perinatol       Date:  2013-01-07       Impact factor: 1.862

7.  TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria.

Authors:  Vijay A K Rathinam; Sivapriya Kailasan Vanaja; Lisa Waggoner; Anna Sokolovska; Christine Becker; Lynda M Stuart; John M Leong; Katherine A Fitzgerald
Journal:  Cell       Date:  2012-07-19       Impact factor: 41.582

Review 8.  Glial modulators as potential treatments of psychostimulant abuse.

Authors:  Patrick M Beardsley; Kurt F Hauser
Journal:  Adv Pharmacol       Date:  2014

9.  Role of cytokine signaling in group B Streptococcus-stimulated expression of human beta defensin-2 in human extraplacental membranes.

Authors:  Erica Boldenow; Kelly A Hogan; Mark C Chames; David M Aronoff; Chuanwu Xi; Rita Loch-Caruso
Journal:  Am J Reprod Immunol       Date:  2014-09-29       Impact factor: 3.886

Review 10.  Non-canonical manifestations of familial Mediterranean fever: a changing paradigm.

Authors:  Donato Rigante; Giuseppe Lopalco; Giusyda Tarantino; Adele Compagnone; Michele Fastiggi; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2015-03-13       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.